Back to Portfolio
Organ-on-ChipDrug DevelopmentMicrofluidicsPreclinical
Invested
2020
Founded
2018
Headquarters
Oulu, Finland
Sector
MedTech
About
FinnAdvance develops multi-channel 3D microfluidic organ-on-chip platforms that simulate human biological barriers including the blood-brain barrier, vascular, and lung tissues for pharmaceutical R&D. Their AKITA product series enables more accurate preclinical drug testing and toxicity screening while reducing reliance on animal models.